wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q57108063-209675D7-056C-4B5E-9640-BD123D7B06A5
Q57108063-209675D7-056C-4B5E-9640-BD123D7B06A5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57108063-209675D7-056C-4B5E-9640-BD123D7B06A5
Advances in the use of PARP inhibitor therapy for breast cancer
P2860
Q57108063-209675D7-056C-4B5E-9640-BD123D7B06A5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57108063-209675D7-056C-4B5E-9640-BD123D7B06A5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0b5584a4546328c3ce85aeb01b95dc5b86e963f1
P2860
Phase I study of olaparib in combination with liposomal doxorubicin in patients with advanced solid tumours.